Liver Disease pp 209-220 | Cite as

Autoimmune Hepatitis

  • John F. Reinus
  • Kristina R. ChackoEmail author


Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease with a wide range of clinical manifestations. Affected individuals may be asymptomatic with mildly elevated serum aminotransferase levels or may present with acute liver failure. While most common in young women, the disease can occur in men and women of all ages and ethnicities. AIH is the result of a complex interaction of environmental triggers, genetic predisposition, and failure of immune tolerance. Immunosuppression with corticosteroids and other immunomodulator therapies are the cornerstones of treatment. Left untreated, AIH can progress to cirrhosis and is the underlying reason for up to 5% of liver transplants.


Immunosuppression Corticosteroids Liver transplantation Serologic testing Liver biopsy Pregnancy 

Further Reading

  1. 1.
    Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–39.CrossRefGoogle Scholar
  2. 2.
    European Association for the Study of the Liver. EASL clinical practice guidelines: autoimmune hepatitis. J Hepatol. 2015;63(4):971.CrossRefGoogle Scholar
  3. 3.
    Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology. 2005;42(1):53–62.CrossRefGoogle Scholar
  4. 4.
    Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, Vierling JM. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51(6):2193–213.CrossRefGoogle Scholar
  5. 5.
    Manns MP, Jaeckel E, Taubert R. Budesonide in autoimmune hepatitis: the right drug at the right time for the right patient. Clin Gastroenterol Hepatol. 2018;16(2):186–9.CrossRefGoogle Scholar
  6. 6.
    Ngu JH, Gearry RB, Frampton CM, Stedman CA. Predictors of poor outcome in patients with autoimmune hepatitis: a population-based study. Hepatology. 2013;57(6):2399–406.CrossRefGoogle Scholar
  7. 7.
    Schramm C, Herkel J, Beuers U, Kanzler S, Galle PR, Lohse AW. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol. 2006;101(3):556.CrossRefGoogle Scholar
  8. 8.
    Verma S, Torbenson M, Thuluvath PJ. The impact of ethnicity on the natural history of autoimmune hepatitis. Hepatology. 2007;46(6):1828–35.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Division of Gastroenterology and Liver DiseasesDepartment of Medicine, Montefiore Medical Center, Albert Einstein College of MedicineBronxUSA

Personalised recommendations